Cargando…
Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice
BACKGROUND: Pancreatic carcinoma usually is a fatal disease with no cure, mainly due to its invasion and metastasis prior to diagnosis. We analyzed the gene expression profiles of paired primary pancreatic tumors and metastatic lesions from Ela-c-myc transgenic mice in order to identify genes that m...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259361/ https://www.ncbi.nlm.nih.gov/pubmed/18218118 http://dx.doi.org/10.1186/1476-4598-7-11 |
_version_ | 1782151382352003072 |
---|---|
author | Thakur, Archana Bollig, Aliccia Wu, Jiusheng Liao, Dezhong J |
author_facet | Thakur, Archana Bollig, Aliccia Wu, Jiusheng Liao, Dezhong J |
author_sort | Thakur, Archana |
collection | PubMed |
description | BACKGROUND: Pancreatic carcinoma usually is a fatal disease with no cure, mainly due to its invasion and metastasis prior to diagnosis. We analyzed the gene expression profiles of paired primary pancreatic tumors and metastatic lesions from Ela-c-myc transgenic mice in order to identify genes that may be involved in the pancreatic cancer progression. Differentially expressed selected genes were verified by semi-quantitative and quantitative RT-PCR. To further evaluate the relevance of some of the selected differentially expressed genes, we investigated their expression pattern in human pancreatic cancer cell lines with high and low metastatic potentials. RESULTS: Data indicate that genes involved in posttranscriptional regulation were a major functional category of upregulated genes in both primary pancreatic tumors (PT) and liver metastatic lesions (LM) compared to normal pancreas (NP). In particular, differential expression for splicing factors, RNA binding/pre-mRNA processing factors and spliceosome related genes were observed, indicating that RNA processing and editing related events may play critical roles in pancreatic tumor development and progression. High expression of insulin growth factor binding protein-1 (Igfbp1) and Serine proteinase inhibitor A1 (Serpina1), and low levels or absence of Wt1 gene expression were exclusive to liver metastatic lesion samples. CONCLUSION: We identified Igfbp1, Serpina1 and Wt1 genes that are likely to be clinically useful biomarkers for prognostic or therapeutic purposes in metastatic pancreatic cancer, particularly in pancreatic cancer where c-Myc is overexpressed. |
format | Text |
id | pubmed-2259361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22593612008-03-04 Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice Thakur, Archana Bollig, Aliccia Wu, Jiusheng Liao, Dezhong J Mol Cancer Research BACKGROUND: Pancreatic carcinoma usually is a fatal disease with no cure, mainly due to its invasion and metastasis prior to diagnosis. We analyzed the gene expression profiles of paired primary pancreatic tumors and metastatic lesions from Ela-c-myc transgenic mice in order to identify genes that may be involved in the pancreatic cancer progression. Differentially expressed selected genes were verified by semi-quantitative and quantitative RT-PCR. To further evaluate the relevance of some of the selected differentially expressed genes, we investigated their expression pattern in human pancreatic cancer cell lines with high and low metastatic potentials. RESULTS: Data indicate that genes involved in posttranscriptional regulation were a major functional category of upregulated genes in both primary pancreatic tumors (PT) and liver metastatic lesions (LM) compared to normal pancreas (NP). In particular, differential expression for splicing factors, RNA binding/pre-mRNA processing factors and spliceosome related genes were observed, indicating that RNA processing and editing related events may play critical roles in pancreatic tumor development and progression. High expression of insulin growth factor binding protein-1 (Igfbp1) and Serine proteinase inhibitor A1 (Serpina1), and low levels or absence of Wt1 gene expression were exclusive to liver metastatic lesion samples. CONCLUSION: We identified Igfbp1, Serpina1 and Wt1 genes that are likely to be clinically useful biomarkers for prognostic or therapeutic purposes in metastatic pancreatic cancer, particularly in pancreatic cancer where c-Myc is overexpressed. BioMed Central 2008-01-24 /pmc/articles/PMC2259361/ /pubmed/18218118 http://dx.doi.org/10.1186/1476-4598-7-11 Text en Copyright © 2008 Thakur et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Thakur, Archana Bollig, Aliccia Wu, Jiusheng Liao, Dezhong J Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice |
title | Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice |
title_full | Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice |
title_fullStr | Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice |
title_full_unstemmed | Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice |
title_short | Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice |
title_sort | gene expression profiles in primary pancreatic tumors and metastatic lesions of ela-c-myc transgenic mice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259361/ https://www.ncbi.nlm.nih.gov/pubmed/18218118 http://dx.doi.org/10.1186/1476-4598-7-11 |
work_keys_str_mv | AT thakurarchana geneexpressionprofilesinprimarypancreatictumorsandmetastaticlesionsofelacmyctransgenicmice AT bolligaliccia geneexpressionprofilesinprimarypancreatictumorsandmetastaticlesionsofelacmyctransgenicmice AT wujiusheng geneexpressionprofilesinprimarypancreatictumorsandmetastaticlesionsofelacmyctransgenicmice AT liaodezhongj geneexpressionprofilesinprimarypancreatictumorsandmetastaticlesionsofelacmyctransgenicmice |